Aktienanalyse zu CME Group Inc (CME)CMECME Group Inc

CME Group Inc. provides a derivatives marketplace. The Company enables clients to trade futures, options, cash and over the counter (OTC) markets, optimize portfolios, and analyze data. It exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural products and metals. It offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it operates central counterparty clearing provider, CME Clearing. Its products provide a means for hedging, speculation and asset allocation related to the risks associated with, among other things, interest rate sensitive instruments, and changes in the prices of agricultural, energy and metal commodities. It provides clearing and settlement services for a range of exchange-traded futures and options on futures contracts and OTC derivatives. It operates in the Financials sector (SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & industry).

CME Group Inc is a good buy right now due to its strong financial performance and positive market indicators. The current price is $293.87, with a forward P/E ratio of 21.93, indicating reasonable valuation relative to future earnings. The RSI is at 86.08, suggesting strong momentum, although it is in overbought territory. The average analyst price target is $300, with some analysts projecting targets as high as $337, indicating potential upside of approximately 14% from the current price. The main risk is the anticipated Federal Reserve rate hike, which could impact overall market sentiment and lead to volatility.

14 analysts cover CME: 9 rate it Buy, 5 Hold and 0 Sell. The average price target is 285.90.